Channeling Innovation
Eli Lilly has partnered with OmniAb on a new ion channel discovery programme, with the deal including an undisclosed upfront payment and up to $370 million in research, development and commercial milestones, plus tiered royalties.
https://t.co/HFZtHrILOh
#nuaxia completes Series A funding and launches “version 2” of its Platform
Read more on our blog or get in touch:
https://t.co/wheEIkDfvy
@mrx@marketresearch#video#research